Q2 2021 13F Holders as of 30 Jun 2021
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
79.8M
-
Number of holders
-
98
-
Total 13F shares, excl. options
-
20.4M
-
Shares change
-
-2.31M
-
Total reported value, excl. options
-
$201M
-
Value change
-
-$22.2M
-
Put/Call ratio
-
0.84
-
Number of buys
-
54
-
Number of sells
-
-40
-
Price
-
$9.86
Significant Holders of Niagen Bioscience, Inc. - Common Stock (NAGE) as of Q2 2021
122 filings reported holding NAGE - Niagen Bioscience, Inc. - Common Stock as of Q2 2021.
Niagen Bioscience, Inc. - Common Stock (NAGE) has 98 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 20.4M shares
of 79.8M outstanding shares and own 25.55% of the company stock.
Largest 10 shareholders include Yong Rong (HK) Asset Management Ltd (4.13M shares), BlackRock Inc. (3.12M shares), VANGUARD GROUP INC (2.61M shares), ICONIQ Capital, LLC (1.3M shares), BANK OF AMERICA CORP /DE/ (1.2M shares), STATE STREET CORP (835K shares), GEODE CAPITAL MANAGEMENT, LLC (821K shares), BARCLAYS PLC (809K shares), Uniplan Investment Counsel, Inc. (679K shares), and NORTHERN TRUST CORP (474K shares).
This table shows the top 98 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.